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The airway vagal preganglionic neurons (AVPNs) in the external formation of the
nucleus ambiguus (eNA) play a major role in the vagal control of tracheobronchial
smooth muscle tone and maintenance of airway resistance. The eNA receives
vasopressinergic projection from the hypothalamic paraventricular nucleus (PVN),
the key node for the genesis of psychological stress. Since airway vagal excitation
is reportedly to be associated with the psychological stress-induced/exacerbated
airway hyperresponsiveness in asthmatics, arginine vasopressin (AVP) might be
involved in stress-related airway vagal excitation. However, this possibility has not
been validated. This study aimed to test whether and how AVP regulates AVPNs. In
rhythmically active medullary slices of newborn rats, retrogradely labeled AVPNs were
identified as inspiratory-activated and inspiratory-inhibited AVPNs (IA- and II-AVPNs)
using patch-clamp techniques according to their inspiratory-related firing behavior
and synaptic activities. The results show that under current clamp, AVP depolarized
both IA- and II-AVPNs, and significantly increased their spontaneous firing rate.
Under voltage clamp, AVP elicited a slow inward current, and significantly increased
the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in both
types of AVPNs. In addition, AVP significantly enhanced the phase-locked excitatory
inspiratory inward current in inspiratory-activated airway vagal preganglionic neurons
(IA-AVPNs), but significantly suppressed the phase-locked inhibitory inspiratory outward
current in II-AVPNs. In both types AVPNs, AVP significantly increased the frequency and
Abbreviations: aCSF, artificial cerebral spinal fluid; AP5, D-2-amino-5-phosphonovalerate; AVP, arginine vasopressin;
AVPNs, airway vagal preganglionic neurons; CNQX, 6-Cyano-7-nitroquinoxaline-2,3-dione; CNS, central nervous system;
CRH, corticotropin-releasing hormone; CSF, cerebrospinal fluid; DMNV, dorsal motor nucleus of the vagus; eNA, the
external formation of the nucleus ambiguus; HPA, hypothalamic-pituitary-adrenocortical; IA-AVPNs, inspiratory-activated
airway vagal preganglionic neurons; II-AVPNs, inspiratory-inhibited airway vagal preganglionic neurons; IPSCs, inhibitory
postsynaptic currents; mEPSCs, miniature excitatory postsynaptic currents; mIPSCs, miniature inhibitory postsynaptic
currents; NA, nucleus ambiguus; pre-BötC, pre-Bötzinger Complex; PVN, paraventricular nucleus; sEPSCs, spontaneous
excitatory postsynaptic currents; sIPSCs, spontaneous inhibitory postsynaptic currents; TTX, tetrodotoxin.
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amplitude of pharmacologically isolated spontaneous GABAergic and glycinergic
inhibitory postsynaptic currents (IPSCs). All of the AVP-induced effects were prevented
by SR49059, an antagonist of V1a receptors, but unaffected by SSR149415, an
antagonist of V1b receptors. AVP did not cause significant changes in the miniature
excitatory postsynaptic currents (mEPSCs), miniature inhibitory postsynaptic currents
(mIPSCs) and membrane input resistance of either type of AVPNs. These results
demonstrate that AVP, via activation of V1a receptors, enhanced the spontaneous
excitatory and inhibitory inputs similarly in the two types of AVPNs, but differentially
altered their phase-locked inspiratory excitatory and inhibitory inputs. The overall effects
of AVP are excitatory in both types AVPNs. These results suggest that increased central
AVP release may be involved in the stress-induced augmentation of airway vagal activity,
and, consequently, the induction or exacerbation of some airway diseases.
Keywords: arginine vasopressin, airway vagal preganglionic neuron, stress, psychological, patch-clamp, asthma
INTRODUCTION
Airway vagal innervation originates principally from two sites
in the brainstem: the nucleus ambiguus (NA) and dorsal motor
nucleus of the vagus (DMNV; Jordan, 2001; Canning, 2006).
Airway vagal preganglionic neurons (AVPNs) within these two
regions serve as the final neural pathways transmitting signals
from the central nervous system (CNS) to peripheral airways
(Haxhiu et al., 2005). Noteworthily, a subset of AVPNs located
in the external formation of the nucleus ambiguus (eNA) plays
a predominant role in supplying cholinergic outflow to airway
smooth muscles, and is crucial in regulating tracheobronchial
caliber and airway resistance (Haselton et al., 1992; Canning
and Fischer, 2001). According to their inspiratory-related
electrophysiological properties in vitro, AVPNs in the eNA
are classified into two categories: the inspiratory-activated and
inspiratory-inhibited AVPNs (IA- and II-AVPNs; Haselton et al.,
1992; Canning and Fischer, 2001). These AVPNs are intrinsically
silent, and their spontaneous or phase-locked inspiratory activity
depends completely on the balance between the excitatory,
mainly glutamatergic, and the inhibitory, mainly γ-aminobutyric
acidergic (GABA) and glycinergic, inputs that they receive.
Alterations in this equilibrium are thought to be associated with
dysregulation of pulmonary vagal functions (Haxhiu et al., 2005;
Chen et al., 2007, 2012; Hou et al., 2012; Zhou et al., 2013; Ge
et al., 2015).
AVPNs receive projections from multiple brain regions
including the hypothalamic paraventricular nucleus (PVN),
the key node for psychological stress to cause emotional and
autonomic disorders (Haxhiu et al., 1993; Hadziefendic and
Haxhiu, 1999; Schlenker et al., 2001; Herman et al., 2008;
Ellenbogen et al., 2010); and a sense of causality has been
prompted between psychosocial stress/negative emotions and
augmentation of airway vagal activity (Isenberg et al., 1992; Ritz
et al., 2010). As is well recognized, increased airway vagal tone
is involved in the pathogenesis of airway hyperreactivity, the
common traits of asthma (Barnes, 1992; Busse and Lemanske,
2001; Aboussafy et al., 2005; Ritz et al., 2012; McAlexander et al.,
2015). Moreover, in asthmatics, bronchial hyperreactivity and
the occurrence of bronchospasm can be induced or exacerbated
by psychological stress, especially negative emotional stimuli
(Heim et al., 1967; Put et al., 2004; von Leupoldt and Dahme,
2013). These lines of evidence indicate a functional connection
between the PVN and the airway vagal centers, which may be
involved in psychological stress-related asthma attack.
In psychological stress, arginine vasopressin (AVP)
synthesized within the PVN is reported to be the initiator
to trigger increased release of corticotrophin-releasing hormone
(CRH) and subsequent activation of the hypothalamic-pituitary-
adrenocortical (HPA) axis (Scaccianoce et al., 1991; Wotjak
et al., 1996; Hatzinger et al., 2000); and the concentration of
AVP is elevated in a stress level-dependent manner, in both
plasma and cerebrospinal fluid (CSF; Bao et al., 2014). More
precisely, AVP-containing fibers originating directly from the
PVN are found just in the vicinity of AVPNs in the eNA (Kc
et al., 2006). It has been widely accepted that AVP can act as a
neuromodulator or transmitter mediating the alterations from
central neuronal activities to psychological status (de Wied et al.,
1993; Raggenbass, 2001; Keck, 2006). These underpinnings make
it reasonable to think that vasopressinergic fibers may supply not
only a morphological but also a functional connection between
the PVN and AVPNs. However, currently it is unknown whether
AVPNs express AVP receptors, and whether and how AVP
regulates AVPNs, although a previous autoradiographic study
found that the region dorsal to the NA shows positive binding
to V1- receptor antagonist (Phillips et al., 1988). Thus this
study aimed to uncover these issues at neuronal and at synaptic
levels using patch clamp, by testing the hypotheses that AVP
activates AVPNs directly and/or by regulating their synaptic
inputs.
MATERIALS AND METHODS
Animals and Ethical Approval
This study was carried out in accordance with the
recommendations of the guidelines for the Care and Use of
Laboratory Animals (1996. National Academy of Sciences,
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Washington, DC, USA). The protocol was approved by the
Animal Ethics Committee of the Fudan University Shanghai
Medical College (no. 20110307-060). Sprague–Dawley rats were
purchased from the Experimental Animal Center of the Chinese
Academy of Science in Shanghai. A total of 101 newborn rats
of either gender were used in this study. Maximal efforts were
made to minimize the number of animals and their suffering.
Retrograde Fluorescent Labeling of AVPNs
and Preparation of Medullary Slices
AVPNs were retrogradely labeled as we have previously
described (Chen et al., 2007, 2012; Ge et al., 2015). In brief,
the 2- to 3-day-old Sprague–Dawley rat was anesthetized with
halothane and hypothermia. The extrathoracic trachea was
exposed through a ventral midline incision in the neck, and
the fluorescent tracer rhodamine (X-rhodamine-5- (and-6)-
isothiocyanate; Molecular Probes, 1% solution, 0.5 µL) was
injected into the smooth muscle at multiple sites of the anterior
tracheal wall between the fourth and the eighth tracheal cartilage
ring. The injection sites were sealed with absorbable gelatin
sponge to prevent or absorb the possible leak of the dye.
After a 48-h recovery, the rat was again deeply anesthetized
and decapitated. The brainstem was isolated and submerged
in cold (4◦C) artificial cerebral spinal fluid (aCSF; mmol L−1:
NaCl, 128; KCl, 3.0; NaHCO3, 24; NaH2PO4, 0.5; CaCl2, 1.5;
MgCl2, 1; and D-glucose, 30) bubbled with 95% O2 and 5%
CO2, and a 500–800 µm thick medullary slice with rhythmic
inspiratory-like hypoglossal bursting (Smith et al., 1991) was
cut using a vibratome (VT 1000S; Leica Microsystems, Wetzlar,
Germany). The slice was then transferred to a recording
chamber (0.6 mL volume) with its rostral section upward,
and superfused with high potassium (KCl, 8 mmol L−1;
Smith et al., 1991) aCSF to allow steady recording of the
rhythmic hypoglossal activity. The temperature of perfusate
was maintained at 23 ± 0.5◦C, and the flow rate was kept at
6–9 mL min−1.
Electrophysiological Recording
The objective AVPNs were identified by the presence of
fluorescence with an Olympus upright microscope (×40 water-
immersion objective lens), as has been shown photographically
in our previous works (Chen et al., 2007, 2012). Under
infrared illumination, the identified AVPNs were imaged with an
infrared-sensitive video detection camera to gain better spatial
resolution and to visually guide and position the patch pipette
onto these identified neurons. When recording the excitatory
postsynaptic currents (EPSCs), the patch pipette (1.5–2.5 MΩ)
was filled with a gluconate-K dominated solution (in mmol L−1:
gluconate-K, 130; HEPES, 10; EGTA, 10; CaCl2, 0.1; 5′-ATP-
K2, 2; MgCl2, 1; pH 7.3). The patch pipette was manipulated
to slowly approach the identified AVPN to obtain a seal over
1 GΩ between the pipette tip and the cell membrane. The
membrane sealing the pipette tip was then ruptured with a
brief suction to gain a whole-cell patch-clamp configuration. The
pipette resistance and capacitance were not compensated either
before or after gaining intracellular access. Under voltage-clamp
recordings, inspiratory-activated airway vagal preganglionic
neurons (IA-AVPNs) were identified as those with the
characteristic rhythmic inspiratory inward currents synchronous
with the periodic inspiratory-like hypoglossal bursts. IA-AVPNs
were normally clamped at −80 mV, and under this clamping
voltage the inhibitory postsynaptic currents (IPSCs) caused
by GABA and glycine are minimized. When putative AVPNs
were clamped at −50 mV or more positive levels, II-AVPNs
were distinguished by rhythmic inspiratory outward currents
synchronous with the hypoglossal bursts. II-AVPNs were
normally clamped at −50 mV, at which the glutamate-induced
inward EPSCs and the GABA- or glycine-induced outward IPSCs
are well separated. Under current clamp, IA-AVPNs exclusively
exhibited rhythmic inspiratory depolarization and bursting
discharge, while II-AVPNs displayed rhythmic inspiratory
hyperpolarization. In some experiments that recorded miniature
excitatory postsynaptic currents (mEPSCs), a 5-mV, 200-ms
hyperpolarizing pulse was applied at a 4-s interval for calculation
of input resistance.
In some experiments, to obtain better recordings of IPSCs,
the patch pipette was filled with a KCl-dominated solution
(in mmol L−1: KCl, 150; HEPES, 10; EGTA, 2; and ATP-
Mg, 2, pH 7.3), and AVPNs were exclusively clamped at
−80 mV. Under this configuration, all the synaptic currents
including the glutamate-mediated inspiratory excitatory currents
in IA-AVPNs and the GABA- or glycine-mediated inspiratory
inhibitory currents in II-AVPNs were inward. In order to
separate the two types of AVPNs from each other, the antagonists
of glutamate receptors were focally implemented onto the
recorded neurons with a puff pipette under the assistance of the
PV830 Pneumatic Picopump pressure delivery system (World
Precision Instruments, Sarasota, FL, USA). IA-AVPNs were
then distinguished from II-AVPNs because their inspiratory
inward currents were reversibly eliminated by the focally applied
antagonists.
The patch-clamp signal was amplified with an Axon
Multiclamp 700B amplifier (Molecular Devices LLC., CA,
USA) with a sampling frequency of 10 kHz, and a filter
frequency of 1 kHz. The activity of the hypoglossal rootlets was
recorded through a suction electrode, amplified with a BMA-931
Bioamplifier (5 kHz sampling frequency, 10–1000 Hz bandpass,
×20,000 magnification; CWE, Ardmore, PA, USA) and
electronically integrated (τ = 200 ms) with an MA-1000 Moving
Averager (CWE). The patch-clamp signal and hypoglossal
activity were digitized with a 1440A Digidata (Molecular Devices
LLC., CA, USA), and collected with the Clampex 10.2 software
(Molecular Devices LLC., CA, USA).
Drug Application
Drugs were normally applied in the bath. AVP ([Arg8]-
Vasopressin, Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2)
was normally used at 100 nM for 1 min. In some experiments,
SR49059 (2S)-1-[[(2R, 3S)-5-Chloro-3-(2-chlorophenyl)-1-
[(3, 4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-hydroxy-1H-
indol-2-yl]carbonyl]-2-pyrrolidinecarboxamide (20 µmol L−1),
a potent and highly selective antagonist of vasopressin
V1a receptors (Serradeil-Le Gal et al., 1993), or SSR149415
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(2S, 4R)-1-[(R)-5-Chloro-1-(2,4-dimethoxy-benzenesulfonyl)-
3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-
hydroxy-pyrrolidine-2-carboxylic acid dimethylamide (10 µmol
L−1; Serradeil-Le Gal et al., 2003), a selective antagonist of
vasopressin V1b receptors (Serradeil-Le Gal et al., 2002), was
applied at least 10 min prior to and during AVP application
to block V1a or V1b receptors, respectively, and the subsequent
AVP application was prolonged to at least 2 min. Strychnine (1
µmol L−1) and bicuculline (50 µmol L−1) were used to block
glycine receptors and GABAA receptors, respectively. CNQX
(6-Cyano-7-nitroquinoxaline-2,3-dione; 50 µmol L−1) and
AP5 (D-2-amino-5-phosphonovalerate; 50 µmol L−1) were
used to block non-NMDA and NMDA glutamate receptors,
respectively. When the neurons were recorded with the
FIGURE 1 | Arginine vasopressin (AVP) significantly depolarized both types of airway vagal preganglionic neurons (AVPNs) and significantly
increased their firing rate during inspiratory intervals. (A1) Recording of a representative inspiratory-activated (IA)-AVPN. Note that AVP (100 nmol L−1) caused
depolarization, increased the firing rate and decreased the amplitude of action potentials. (B1) Selected traces (upper trace) captured from (A1) are presented in an
enlarged time-scale along with the simultaneous hypoglossal activity (lower trace), showing the firing during control (left) and AVP application (right). Please note that
the IA-AVPN had no spontaneous firings during inspiratory intervals under the control condition but fired continuously in the presence of AVP. (A2) Similarly, AVP
(100 nmol L−1) caused depolarization and increased the firing rate in a representative inspiratory-inhibited (II)-AVPN. (B2) Selected traces captured from (A2) are
presented in an enlarged time-scale, showing that the sporadic action potentials during control recording became almost continuous after application of AVP, and
the rhythmic inspiratory hyperpolarization became less pronounced. (C1,C2) Bar graphs showing the membrane potential in average before and during AVP
application in IA-AVPNs (C1, n = 6) and II-AVPNs (C2, n = 6). Note the AVP-induced significant change. (D1,D2) Bar graphs showing the spontaneous firing rate in
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FIGURE 2 | AVP significantly increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) and enlarged the rhythmic
inspiratory inward currents in IA-AVPNs. (A) Recording of a representative IA-AVPN under voltage clamp, showing that AVP (100 nmol L−1) caused a slow inward
current and increased the frequency of the rhythmic inspiratory inward currents. (B) Selected traces captured from (A) are presented in enlarged time-scale along
with the simultaneous hypoglossal activity, showing that AVP increased the frequency of sEPSCs during inspiratory intervals. (C) Comparison of the representative
inspiratory inward current envelopes during control and AVP application, showing the AVP-induced changes. (D,E) Bar graphs for the frequency (D) and amplitude
(E) of sEPSCs in averages (n = 10). Please note that the frequency but not amplitude of sEPSCs was significantly increased by AVP. (F) Bar graphs for the indices of
inspiratory inward currents, showing the AVP-induced significantly increases in the peak amplitude, duration and area (n = 10). Freq., frequency; Amp., amplitude.
KCl-dominated pipette solution, CNQX and AP5 were first
implemented focally to identify the type of the AVPN, and then
included in the perfusate along with strychnine or bicuculline
to isolate GABAergic or glycinergic IPSCs. Tetrodotoxin (TTX,
1 µmol L−1) was added to the perfusate in some experiments
recording mEPSCs or miniature inhibitory postsynaptic currents
(mIPSCs). SR49059, SSR149415, CNQX and bicuculline were
firstly dissolved in DMSO and the other drugs in deionized
water to make fresh stock solutions, and then diluted at least
1000 times with aCSF for experimental use. In each slice,
only one AVPN was tested and each agonist or antagonist
of vasopressin receptors was applied only once to minimize
desensitization. AVP and SR49059 were purchased from Tocris
Bioscience (Bristol, UK), SSR149415 was purchased from
Axon Medchen (Groningen, Netherlands), and the rest of the
drugs were purchased from Sigma-Aldrich (St Louis, MO,
USA).
Data Analysis
Spontaneous and miniature synaptic currents were analyzed
with the MiniAnalysis software (version 4.3.1; Synaptosoft,
Fort Lee, NJ, USA) with the minimal acceptable amplitude at
10 pA. When analyzing spontaneous excitatory postsynaptic
currents (sEPSCs) occurred during the inspiratory intervals,
the phase-locked inspiratory inward or outward currents were
ignored. In each AVPN, a 1-min recording during control,
AVP implementation, antagonist (SR49059 or SSR149415)
application, or co-application of AVP and antagonist
was analyzed for comparison. The rhythmic inspiratory
inward/outward currents were analyzed with the Clampfit
10.2 software (Molecular Devices LLC.). Before analyzing the
inspiratory inward or outward currents, at least five consecutive
inspiratory bursts during control or drug application were
low-pass-filtered at 5 Hz with an eight-pole Bessel filter and
averaged for comparison, and the values during drug application
were expressed as the ratios of control values (set as 1). When
only two groups of results were statistically compared, paired
or independent t-test was used when appropriate. When
more than two groups of results were compared, generally
one-way analysis of variance (ANOVA) followed by Bonferroni
correction was applied, and additional paired t-test was used
when appropriate. The results are normally presented as
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means ± SE, and the number of neurons or slices is expressed
as ‘‘n’’. The criterion for statistical significance was set at
p< 0.05.
RESULTS
AVP Depolarized AVPNs and Significantly
Increased Their Spontaneous Firing Rate
AVP (100 nmol L−1) prominently depolarized both types of
the AVPNs. The maximal depolarization ranged from 6 mV to
11 mV (mean 9 ± 2 mV, n = 6) in IA-AVPNs and 3 mV to
6 mV (mean 4 ± 1 mV, n = 6) in II-AVPNs. In both types
of AVPNs, AVP significantly elevated the membrane potential
to more positive levels (Figures 1A1–C1, A2–C2), significantly
increased the spontaneous firing rate (Figures 1D1,D2), and
slightly decreased the amplitude of action potentials. In addition,
the frequency of the rhythmic hypoglossal bursts, as well as the
synchronous inspiratory bursts in IA-AVPN and the inspiratory
hyperpolarization in II-AVPN, was significantly increased, from
4.8 ± 2.1 bursts min−1 of control to 8.3 ± 2.5 bursts min−1
maximally during (after) application of AVP (P < 0.001, n = 14).
In II-AVPNs, notably, the inspiratory hyperpolarization became
less identifiable after AVP application (Figures 1A2,B2). The
AVP-induced effects started within 2 min after application of
AVP, lasted for 8–10 min, and were reversible.
AVP Increased the Frequency of sEPSCs in
Both Types of AVPNs, Augmented the
Inspiratory Inward Currents in IA-AVPNs,
but Suppressed the Inspiratory Outward
Currents in II-AVPNs
AVP (100 nmol L−1) significantly increased the frequency of
sEPSCs, in both IA-AVPNs (Figures 2A,B,D) and II-AVPNs
(Figures 3A,B,D), but did not significantly alter the amplitude
of sEPSCs in either type of AVPNs (Figures 2E, 3E). And in
IA-AVPNs, AVP significantly enhanced the inspiratory inward
currents with respect to the peak amplitude, duration and
area (Figures 2C,F); whereas in II-AVPNs, AVP significantly
suppressed the peak amplitude and area of the inspiratory
FIGURE 3 | AVP significantly increased the frequency of sEPSCs, but attenuated the rhythmic inspiratory outward currents in II-AVPNs. (A) Recording
of a representative II-AVPN under voltage clamp, showing that AVP (100 nmol L−1) caused a slow inward current and a distinct inhibition of the inspiratory outward
currents. (B) Selected traces captured from (A) are presented in an enlarged time-scale, along with the simultaneous hypoglossal activity, showing the increase in the
frequency of sEPSCs and the reduction of inspiratory outward currents. (C) Comparison of the representative inspiratory outward current envelopes during control
and AVP application, showing the AVP-induced changes. (D,E) Bar graphs for the frequency (D) and amplitude (E) of sEPSCs in averages (n = 6). (F) Bar graphs for
the indices of inspiratory outward currents (n = 6), showing the AVP-induced changes in the peak amplitude and area.
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outward currents (Figures 3C,F). Additionally, AVP caused a
slow inward current in both types of AVPNs (Figures 2A, 3A),
of which the maximal amplitude ranged from 40 pA to 110 pA
in IA-AVPNs (mean 73 ± 8 pA, n = 9) and 31–101 pA in
II-AVPNs (mean 64 ± 11 pA, n = 6), respectively. At the end of
the experiments, all of the excitatory inward currents, no matter
spontaneous or phasic inspiratory, were eliminated by 50 µmol
L−1 CNQX.
The AVP-Induced Slow Inward Current,
Frequency Increase of sEPSCs and the
Changes in Phasic Inspiratory Currents in
Both Types of AVPNs were Prevented by
SR49059, but Unaffected by SSR149415
After pretreatment with SR49059 (20 µmol L−1), an antagonist
of V1a receptors, AVP no longer caused a noticeable slow inward
current, and did not cause significant changes in respects of
sEPSCs and phasic inspiratory currents in either IA-AVPNs
(Figure 4) or II-AVPNs (Figure 5). In addition, SR49059 itself
had no effect on either AVPNs or the hypoglossal activity.
In contrast, SSR149415 (10 µmol L−1), an antagonist of V1b
receptors, failed to block the effects of AVP. After pretreatment
with SSR149415, AVP still caused a significant frequency increase
of sEPSCs in both IA-AVPNs (Figures 6C,D) and II-AVPNs
(Figures 7C,D), and induced a noticeable slow inward current
(Figures 6A,B, 7A,B), of which the maximal amplitude ranged
from 35 pA to 80 pA in IA-AVPNs (mean 57 ± 7 pA,
n = 6) and 40–80 pA in II-AVPNs (mean 55 ± 7 pA,
n = 6), respectively, and is not significantly different with
that without the presence of SSR149415 (P = 0.26 in IA-
AVPNs, P = 0.51 in II-AVPNs; independent t-test). And,
like it did without SSR149415, AVP significantly augmented
the inspiratory inward currents in IA-AVPNs (Figure 6E),
and suppressed the inspiratory outward currents in II-AVPNs
(Figure 7E). Similarly, SSR149415 itself had no effect on either
AVPNs or the hypoglossal activity.
AVP Significantly Increased the Frequency
and Amplitude of GABAergic Spontaneous
IPSCs (sIPSCs), All of Which were
Prevented by SR49059
In both types of the AVPNs, AVP (100 nmol L−1) significantly
increased not only the frequency but also the amplitude
of the pharmacologically isolated GABAergic spontaneous
inhibitory postsynaptic currents (sIPSCs). Recording segments in
Figure 8A1 showed the pharmacologically isolated GABAergic
sIPSCs from a representative IA-AVPN during control and AVP
application, for which the AVP-induced frequency increase is
FIGURE 4 | The AVP-induced changes in sEPSCs and inspiratory inward currents in IA-AVPNs were prevented by SR49059, a selective antagonist of
V1a receptors. (A) Recording of a representative inspiratory-activated (IA)-AVPN, showing that after pretreatment with SR49059 (20 µmol L−1), AVP (100 nmol L−1)
caused little changes in the baseline current, sEPSCs and inspiratory inward currents. Note that SR49059 itself had little effects. (B) Selected traces captured from
(A) are presented in an enlarged time-scale, along with the simultaneous hypoglossal activity. (C–E) Summarized data for the frequency (C) and amplitude (D) of
sEPSCs in average (n = 6), and for the indices of inspiratory inward currents (E, n = 6).
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FIGURE 5 | The AVP-induced changes in sEPSCs and inspiratory outward currents in II-AVPNs were prevented by SR49059. (A) Recording of a
representative II-AVPN, showing that after pretreatment with SR49059 (20 µmol L−1), AVP (100 nmol L−1) caused little changes in the baseline current, sEPSCs and
inspiratory outward currents. (B) Selected traces captured from (A) are presented in an enlarged time-scale, along with the simultaneous hypoglossal activity.
(C–E) Summarized data for the frequency (C) and amplitude (D) of sEPSCs in average (n = 8), and for the indices of inspiratory outward currents (E, n = 6).
exhibited by a leftward shift of the cumulative distribution curve
of inter-event intervals (Figure 8B1), and the AVP-induced
amplitude increase by a rightward shift of the distribution
curve of amplitude (Figure 8C1). Summarized (averaged) data
for the frequency and amplitude of GABAergic sIPSCs in
IA-AVPNs were shown in Figures 8D1,E1. Similar set of
data from individual and multiple II-AVPNs were shown in
Figures 8A2–E2.
All of the effects of AVP on GABAergic sIPSCs were
prevented by pre-application of SR49059 (20 µmol L−1), in both
IA-AVPNs (Figures 8F1,G1) and II-AVPNs (Figures 8F2,G2).
AVP Significantly Increased the Frequency
and Amplitude of Glycinergic sIPSCs in
Both Types of AVPNs, All of Which were
Blocked by SR49059
Similar as it did on GABAergic sIPSCs, AVP (100 nmol L−1)
significantly increased the frequency as well as the amplitude
of the pharmacologically isolated glycinergic sIPSCs, in both
IA-AVPNs (Figures 9A1–E1) and II-AVPNs (Figures 9A2–E2).
Pre-application of SR49059 also abolished the effects of AVP
on glycinergic sIPSCs in both IA-AVPNs (Figures 9F1,G1) and
II-AVPNs (Figures 9F2,G2).
AVP had no Effect on mEPSCs, mIPSCs
and Membrane Input Resistance
After pre-treatment with TTX (1 µmol L−1), AVP
(100 nmol L−1) did not cause significant changes in mEPSCs and
mIPSCs, in either the frequency or amplitude, and in either type
of AVPNs (data not shown). AVP failed to induce a significant
change of the membrane input resistance, in either IA-AVPNs or
II-AVPNs (data not shown). In the majority (12/15) of AVPNs,
AVP no longer caused a measurable change in the baseline
current; however it still elicited a slight slow inward current in a
minority (3/15) of them, of which the maximal amplitude ranged
from 21 pA to 36 pA.
DISCUSSION
This study has the following findings: (1) AVP depolarized
both types of AVPNs and significantly increased the firing rate
during inspiratory intervals; (2) AVP significantly increased
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FIGURE 6 | The AVP-induced changes in sEPSCs and inspiratory inward currents in IA-AVPNs were unaffected by SSR149415, a selective antagonist
of V1b receptors. (A) Recording of a representative IA-AVPN, showing that after pretreatment with SSR149415 (10 µmol L−1), AVP (100 nmol L−1) caused similar
responses as it did without SSR149415. (B) Selected traces captured from (A) are shown in an enlarged time-scale, along with the simultaneous hypoglossal
activity. (C–E) Summarized data for the frequency (C) and amplitude (D) of sEPSCs in average (n = 6), and for the indices of inspiratory inward currents (E, n = 6).
∗ p < 0.05, obtained from additional paired t-test.
the frequency of sEPSCs and caused a slow inward current
in both types of AVPNs; (3) AVP significantly increased not
only the frequency but also the amplitude of GABAergic and
glycinergic sIPSCs in both types of AVPNs; (4) AVP significantly
increased the intensity of the phase-locked inspiratory inward
currents in respects of peak amplitude, duration and area in IA-
AVPNs, but suppressed that of the inspiratory outward currents
in II-AVPNs; (5) The AVP-induced changes were prevented by
SR49059, an antagonist of V1a receptor, but not by SSR149415,
an antagonist of V1b receptor; and (6) AVP had no impact on
mEPSCs, mIPSCs and membrane input resistance in either type
of AVPNs.
In the present study, AVP significantly increased the
frequency of sEPSCs, and significantly increased both the
frequency and amplitude of sIPSCs in both types of the AVPNs.
While in the pre-existence of TTX, AVP failed to alter either the
frequency or amplitude of mEPSCs and mIPSCs. These results
prompt that the AVP-induced enhancement of sEPSCs or sIPSCs
is action potential-dependent, and tend to rule out an effect
of AVP on the presynaptic terminals of AVPNs. Most likely,
the enhancement occurs on the somatodendritic membrane of
the excitatory or inhibitory neurons presynaptic to AVPNs.
This study also found that in most IA- and II-AVPNs, after
pretreatment with TTX, the AVP-elicited slow inward currents
disappeared; and in neither type of AVPNs, did AVP significantly
alter the membrane input resistance. These results suggest that in
most AVPNs, AVP has hardly a postsynaptic effect; and, when
TTX was absent, the AVP-induced slow inward current might
be primarily, if not completely, due to the summation of the
enhanced synaptic inputs. However, in aminority (3/15) AVPNs,
AVP did cause a slow inward current in the preexistence of TTX.
This result suggests that vasopressin V1a receptors, even truly
expressed in AVPNs, the density might vary markedly among
individual neurons. As a limitation, this study does not supply
further immunohistological evidence regarding the expression of
vasopressin V1a receptors in AVPNs.
AVP significantly facilitated both the sEPSCs and sIPSCs
of AVPNs. And, as is mentioned above, in most AVPNs,
AVP showed little direct postsynaptic effect. However, AVP
exclusively caused depolarization of AVPNs. These results
suggest that in the integrated effect of AVP on AVPNs, the
enhancement of excitatory inputs play an overwhelming role
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FIGURE 7 | The AVP-induced responses in II-AVPNs were unaffected by SSR149415. (A) Recording of a representative II-AVPN, showing that after
pretreatment with SSR149415 (10 µmol L−1), AVP (100 nmol L−1) caused similar responses as it did without SSR149415. (B) Selected traces captured from (A) are
shown in an enlarged time-scale, along with the simultaneous hypoglossal activity. (C–E) Summarized data for the frequency (C) and amplitude (D) of sEPSCs in
average (n = 7), and for the indices of inspiratory outward currents (E, n = 6).
over the enhancement of inhibitory inputs. On the other hand,
it should be born in mind that in our study, AVP was applied
globally in the bath and it acted on the excitatory and inhibitory
inputs of AVPNs without any temporal and spatial selectivity.
However in intact CNS, vasopressinergic neurons are located in
multiple brain nuclei (de Vries and Miller, 1998), and they might
be activated by different types of stimuli and neuronal circuits.
Therefore, it is possible that physiologically, the excitatory
and inhibitory inputs of AVPNs are independently modulated
by AVP; and AVP-induced extraordinary augmentation of
individual type of inputs might cause dysregulation of airway
vagal function.
AVP increased the frequency of the inspiratory inward
currents in IA-AVPNs and that of the inspiratory outward
currents in II-AVPNs. Given that the inspiratory EPSCs or
IPSCs are rhythmically activated, the corresponding neurons
presynaptic to AVPNs obviously receive the control from the
inspiratory rhythmogenic neuronal network such as the pre-
Bötzinger Complex (pre-BötC), or they themselves might right
be the rhythmogenic neurons. A number of vasopressinergic
fibers originating from the PVN do project to the pre-BötC,
in which a subpopulation of neurons are immunoreactive for
V1a receptors; and microinjection of AVP into the pre-BötC
caused a marked increase of respiratory rate (Kc et al., 2002).
Thus it makes sense to infer that AVP might excite the excitatory
rhythmogenic neurons in the pre-BötC and consequently
increase both the frequency and the intensity of inspiratory
inward currents.
Surprisingly, in II-AVPNs, AVP attenuated the inspiratory
hyperpolarization under current clamp and significantly
suppressed the peak amplitude and area of the inspiratory
outward currents under voltage clamp. In view of the fact that
AVP facilitated the pharmacologically isolated GABAergic
and glycinergic sIPSCs of II-AVPNs, the suppression of the
inspiratory outward currents by AVP is quite impressive. It
must be emphasized that in our study, the inspiratory inward
currents in IA-AVPNs were recorded with a holding voltage of
−80 mV, at which the inhibitory synaptic currents mediated by
GABA and glycine are minimized. As a result, the inspiratory
inward currents in IA-AVPNs are not disturbed by inhibitory
synaptic currents, and their enhancement by AVP might thus
be fully revealed. While in II-AVPNs, the inspiratory outward
currents were recorded at a holding voltage of −50 mV, at
which the inhibitory synaptic currents are outward and the
excitatory currents are inward. It should be born in mind that
in II-AVPNs, excitatory inputs are also present during the
inspiratory phase. Since AVP facilitated both the sEPSCs and
the pharmacologically isolated sIPSCs of both types AVPNs,
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FIGURE 8 | AVP significantly increased the frequency and amplitude of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) in both
types of AVPNs, all of which were prevented by SR49059. (A1) Representative recording segments of GABAergic sIPSCs from an IA-AVPN during control
(upper panel) and AVP application (100 nM, lower panel), showing the AVP-induced changes in the frequency and amplitude. (B1,C1) Cumulative plots of the
sIPSCs intervals (B1) and amplitude (C1) during control (continuous line) and AVP application (dotted line; Plotted from the same IA-AVPN in A1). Note that AVP
caused a leftward shift in the interval distribution curve and a rightward shift in the amplitude distribution curve, indicating increases in the frequency and amplitude,
respectively. (D1,E1) Bar graphs for the frequency and amplitude of GABAergic sIPSCs in average in IA-AVPNs (n = 6). (F1,G1) SR49059 (20 µmol L−1) prevented
the AVP-induced increase in the frequency and amplitude (n = 6). (A2–G2) AVP caused similar changes in the GABAergic sIPSCs of II-AVPNs (n = 6) as in those of
IA-AVPNs; and all of which were also prevented by SR49059 (n = 6).
and, as is mentioned above, the AVP-induced facilitation of
excitatory inputs seemingly surpasses that of inhibitory inputs,
it is possible that in II-AVPNs, the excitatory inputs during
the inspiratory phase were also enhanced by AVP. As a result,
the inspiratory outward currents in II-AVPNs, whether altered
by AVP independently or not, might be counteracted by an
AVP-induced facilitation of the inward excitatory synaptic
currents. In the present study, the sIPSCs and phasic inspiratory
outward currents showed differential responses to AVP, which
is somewhat consistent with the findings in our previous
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FIGURE 9 | AVP significantly increased the frequency and amplitude of glycinergic sIPSCs in both types of AVPNs, all of which were prevented by
SR49059. (A1) Representative traces of glycinergic sIPSCs from an IA-AVPN manifested the details during control (upper panel) and AVP application (100 nmol L−1,
lower panel), showing the AVP-induced changes in the frequency and amplitude. (B1,C1) Cumulative plots of the sIPSCs intervals (B1) and amplitude (C1) during
control (continuous line) and AVP application (dotted line; plotted from the same II-AVPN in A1). Note that AVP caused a leftward shift in the interval distribution curve
and a rightward shift in the amplitude distribution curve, indicating increases in the frequency and amplitude, respectively. (D1,E1) Bar graphs for the frequency and
amplitude of glycinergic sIPSCs in average in IA-AVPNs (n = 8). (F1,G1) SR49059 (20 µmol L−1) prevented the AVP-induced increase in the frequency and amplitude
(n = 6). (A2–G2) AVP caused similar changes in the glycinergic sIPSCs of II-AVPNs as in those of IA-AVPNs (n = 6), and all of which were also prevented by SR49059
(n = 6).
studies. One study found that thyrotropin-releasing hormone
significantly suppressed the inspiratory outward currents of
II-AVPNs while has no effect on their sIPSCs (Hou et al., 2012).
Another found that an agonist of α1-adrenoceptors significantly
enhanced the inspiratory outward currents of II-AVPNs but
had no effect on their pharmacologically isolated GABAergic or
glycinergic sIPSCs (Ge et al., 2015). Therefore, it is more possible
that the inspiratory-related inhibitory inputs of II-AVPNs,
which are primarily glycinergic (Hou et al., 2012), are somewhat
different from the spontaneous inhibitory inputs in respect of the
origin, and their inspiratory-related activity may be modulated
distinctively.
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So far, three types (V1a, V1b and V2) of high-affinity receptors
for AVP have been cloned and characterized by their primary
structure, gene localization and functions. Among them, V1a
and V1b receptors are found exclusively in the CNS (Koshimizu
et al., 2012). And, in the brainstem, only V1a receptors are
abundantly expressed (Go´z´dz´ et al., 2003). SR49059, a selective
antagonist of V1a receptors, shows high binding affinity for V1a
receptors (rat: Ki = 2.2 nmol L−1) relative to V1b andV2 receptors
(Serradeil-Le Gal et al., 1993); while SSR149415 exhibits high
affinity for V1b receptors (rat: Ki = 3.7 nmol L−1; Serradeil-Le
Gal et al., 2002). SR49059 alone completely blocked all of the
AVP-induced effects, whereas SSR149415 failed to do so. These
data strongly suggest that in this study, the AVP-induced changes
in AVPNs are mediated by V1a receptors. This conclusion
is in accordance with the notion that the central actions of
AVP are mainly, if not exclusively, mediated by V1a receptors
(Raggenbass, 2001).
Morphologically, AVP-containing fibers originating from
the PVN project to the vicinity of AVPNs (Kc et al., 2006),
and functionally, the results from our present study further
certified that AVP do excite those AVPNs. AVP, as well as
CRH (also excites the AVPNs, unpublished observation), is
critically involved in the occurrence of psychological stress. It
is likely that during the process of psychological stress, elevated
central AVP leads to airway vagal excitation via activation
of AVPNs, which subsequently induces or exacerbates asthma
as is supposed by literatures (Ritz et al., 2010). Therefore,
this study has provided a new insight for the contribution
of stress in the induction or exacerbation of asthma. In
fact, in the preliminary experiments of a prospective study,
we have primarily validated that intracisternal application of
SR49059 significantly attenuated the decrease of ventilatory
function in ovalbumin-sensitized rats, via inhibition of airway
vagal tone (unpublished data).
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